Therapeutic Targets For Inflammation And Cancer Novel Therapies For Digestive Diseases

This unique book deals with both inflammation and cancer in a single source of publication. They are seldom grouped together although it has been known that both diseases are closely associated, particularly in the gastrointestinal tract and liver. As the book touches on two such major areas of diseases in humans, it should be of interest to a wider audience of researchers and readers. It is noted that the book combines the effort of both basic scientists and clinicians from different countries with extensive experiences in molecular biology and clinical practice to unveil the most updated picture of the pathogenesis and therapeutic strategies in the treatment of inflammation and cancer in the digestive tract. In this regard, potential pathogenic modulators and also therapeutic options are widely discussed. These types of information would definitely broaden our knowledge in better understanding these diseases. Contents:General Introduction to Inflammation and Cancer in the Digestive Tract (Ming Xing Li and Chi Hin Cho)Inflammation and Therapeutics in the Digestive Tract:Brain–Gut Relationship on Mucosal Inflammation in the Gastrointestinal Tract (Klara Gyires and Ágnes Fehér)Nesfatin-1: The Novel Appetite Peptide with Therapeutic Efficacy to Prevent Acute Hemorrhagic Gastric Lesions and Accelerate Gastric Ulcer Healing (Aleksandra Szlachcic, Jolanta Majka, and Tomasz Brzozowski)Chemoprophylaxis in Inflammatory Bowel Disease (Nikola Mitrev, Aladdin Alswaifi, and Rupert W Leong)Targeting the Nuclear Receptor HNF4α as a Potential Therapy for Gut Inflammation and Cancer (Jean-Philippe Babeu and François Boudreau)Established Therapies and New Therapeutic Strategies in Alcoholic Liver Disease (Helmut Karl Seitz and Sebastian Mueller)Carcinogenesis and Therapeutic Targets in the Gastrointestinal Tract:Targets of Tumor Epigenetics and Its Microenvironment in Gastrointestinal Cancer (Ssu-Yin Yen, Hong-Meng Chuang, Mao-Hsuan Huang, Sheng-Feng Tsai, Tzyy-Wen Chiou, Hong-Lin Su, Li-Ing Ho, Shinn-Zong Lin, and Horng-Jyh Harn)Esophageal Cancer: From Bench to Bedside (Gang Ma and Zhihua Liu)Angiogenesis and Lymphangiogenesis in Gastric MALT Lymphoma: Relation of VEGF and VASH2 (Masahiko Nakamura, Anders Øverby, and Hidenori Matsui)NF-κB as a Potential Molecular Target for Therapy of Gastrointestinal Cancers (Nathan Palmer, Muthu K Shanmugam, Gautam Sethi, and Philipp Kaldis)Hypoxia-Inducible Factor-1κ Modulation in Colorectal Carcinogenesis (Francesco Mariani, Stefano Mancini, Paola Sena, and Luca Roncucci)Therapeutic Approaches Targeting the Serrated Pathway of Colorectal Cancer Characterized by Mutation in the BRAF Gene and Overexpression of GTPase Rac1b (Paulo Matos, Vânia Gonçalves, and Peter Jordan)The "Yin" and "Yang" of Target-Oriented Anticancer Phytochemicals Derived from Herbal Medicines (Kathy K Auyeung and Joshua K S Ko)The Degradation System of Prostaglandin E2 in Gastrointestinal Cancer (Tetsuya Tanigawa, Toshio Watanabe, Shogo Takeda, Hiroshi Tatsuwaki, Masatsugu Shiba, Kazunari Tominaga, Yasuhiro Fujiwara, and Tetsuo Arakawa)Prostaglandin and Its Receptors: Potential Targets for Gastrointestinal Inflammation and Cancer (Vivian Y Shin and Ava Kwong)Autophagy and microRNAs as the Therapeutic Targets in Gastrointestinal Cancers:Modulation of Autophagy as a Potential Therapeutic Target for Gastrointestinal Cancers: Promises and Uncertainties (Li Ma)microRNAs as Therapeutic Targets for Gastric Cancer (Takatsugu Ishimoto and Hideo Baba)microRNA-based Novel Therapeutic Development in Gastrointestinal Cancer (Andrew Fesler and Jingfang Ju)Unraveling the Relationship between Autophagy and microRNA in Gastrointestinal Cancer (Yuanyuan Yin, Peiqi Wang, Yaxin Zheng, Yi Chen, and Jinhui Wang) Readership: Basic and clinical researchers in the fields of inflammation, hepatology, pathology, pharmacology, oncology and gastroenterology. Can be used as a reference for their research and clinical practice in academic and industrial sectors.

Chronic inflammation is a component of many disease conditions that affect a large group of individuals worldwide, which is characterized by persistent, low-grade inflammation and is increased in the aging population. It occurs when an initiating stimulus is not removed or if the resolution process is disrupted, resulting in a state of low-grade inflammation. It is acknowledged that chronic inflammatory diseases are involved in cardiovascular diseases, endocrine disease, neurodegenerative disease, hepatic disease, pulmonary disease, gastrointestinal disease, and cancer et al., including but not limited to atherosclerosis, diabetes, multiple sclerosis, fibrosis, NAFLD, COPD, inflammatory bowel disease, autoimmune disorders (like SLE, RA), which are major causes of death worldwide. Therefore, it is necessary to explore novel targets and therapeutic drugs for chronic inflammatory diseases.

This volume examines in detail the role of chronic inflammatory processes in the development of several types of cancer. Leading experts describe the latest results of molecular and cellular research on infection, cancer-related inflammation and tumorigenesis. Further, the clinical significance of these findings in preventing cancer progression and approaches to treating the diseases are discussed. Individual chapters cover cancer of the lung, colon, breast, brain, head and neck, pancreas, prostate, bladder, kidney, liver, cervix and skin as well as gastric cancer, sarcoma, lymphoma, leukemia and multiple myeloma.

Early recognition and management of adverse effects of cancer treatments are essential for optimal care of patients with cancer, and drastically different approaches are required for different physiologic reactions. Handbook of Cancer Treatment-Related Symptoms and Toxicities is a focused, one-stop resource that enables clinicians to quickly find up-to-date, reliable information needed at the point of care. The high-yield approach prioritizes the most common toxicities associated with cancer treatment, and concise, templated chapters offer fast access to information needed in day-to-day practice. Presents a user-friendly overview of cancer treatment-related symptoms and toxicities management in a practical, easy-to-use format, allowing you to quickly find information in one convenient, concise resource. Covers systemic and radiation therapies, including chemotherapy, immunotherapy, targeted therapies, and radiation therapy, detailing symptoms of each toxicity to confirm your diagnosis. Overviews pharmacologic and non-pharmacologic approaches to symptom management. Offers recommendations for mitigating toxicities in high-risk patients. Discusses key topics such as management of infusion reactions, when the need for biopsy is warranted, and the unique challenges posed by novel immunotherapies.

These negative regulatory mechanisms of the intestinal immune system are disturbed in certain disease conditions, causing the immunocompetent cells to respond to food components and commensal bacteria by becoming activated and to overproduce inflammatory cytokines and chemokines. These disease conditions include food allergies, such as celiac disease, and the inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease, although their exact etiological mechanisms remain to be revealed. --Book Jacket.

Inflammation and cancer are two major disorders that cause huge concerns in our society. However, what one may not know is that both diseases are closely associated and, in particular, both occur in the gastrointestinal tract and liver. This book describes the mechanics of how inflammation can progress to cancer in these organs. The authors in this book comprehensively discuss the different biomarkers for early diagnosis, and current therapeutic treatments for these diseases. All of these would allow us to better understand the pathogenesis of both diseases. As such, this book provides comprehensive information concerning the interrelationship between inflammation and cancer in a cohesive manner, and the information derived would benefit not only basic scientists but also clinicians who are working in these fields. Contents:Inflammation and Cancer:General Introduction (Chung Wah Wu and Jun Yu)General Mechanisms of Inflammation (Liwei Lu and Min Yang)Genetic and Epigenetic Alterations in Inflammation-Related Cancers — General Mechanisms of Cancers (Yasuyuki Okamoto and Yutaka Kondo)From Inflammation to Cancer: The Molecular Basis (Hongchuan Jin)Models of Chronic Inflammation–Induced Cancers and Their Treatments:Advances in the Treatment of Helicobacter pylori Infection and Gastric Cancer (Guy D Eslick)Inflammatory Bowel Disease and Colorectal Cancer and Their Treatment (Crispin Corte and Rupert WL Leong)Hepatitis B and Hepatocellular Carcinoma and Their Treatment (Chi-Jen Chu, Teh-Ia Huo and Shou-Dong Lee)Hepatitis C and Hepatocellular Carcinoma: Implications for Pathogenesis and Treatment (Geoffrey C Farrell)Advances in the Interventional Therapies for Hepatocellular Carcinoma (Carmen Chi Min Cho, Joyce Wai Yi Hui and Simon Chun Ho Yu)Mediators in Chronic Inflammation and Cancers:Exploration of Cytokine Signaling in Clinical Management of Hepatocellular Carcinoma (Xuelian Zhao and Xin Wei Wang)Role of Nuclear Factor-κB Pathway in Gastrointestinal Inflammation and Cancer (Muthu K Shanmugam, Nadine Upton, Gautam Sethi and WS Fred Wong)Novel Mediators for Chronic Inflammation and Oncogenic Transformation: Tumor Necrosis Factor (TNF)-α (Naofumi Mukaida and Boryana K Popivanova)Peroxisome Proliferator Activated Receptor-γ (PPARγ): Roles in Chronic Inflammation and Intestinal Oncogenic Transformation (Ioannis A Voutsadakis)Proteinase-Activated Receptors (Hongying Wang)Molecular Markers of Cancers and Their Clinical Implications:Use of Tumor Markers in the Detection and Management of Patients with Colorectal Cancer (Michael J Duffy)Genetic Biomarkers for the Diagnosis and Prognosis of Hepatocellular Carcinoma (John M Luk, Angela M Liu, Kwong-Fai Wong and Ronnie T P Poon)Summary:Current Therapy and Future Perspectives for Inflammation-Associated Cancer (L Zhang and C H Cho) Readership: Both basic and clinical researchers in a variety of fields including cancer, gastroenterology, hepatology, pathology, pharmacology and radiology. Keywords:COX-2;Gastric Cancer;Colorectal Cancer;Gastrointestinal Tract;Hepatitis;Hepatocellular Carcinoma;Helicobacter Pylori;Inflammatory Bowel Disease;Nuclear Factor-κB;Peroxisome Proliferator Activated Receptor-γ;Tumor Markers;Tumor Necrosis Factor-αKey Features:Two important subjects described in a single publicationA diversified panel of contributors from Asia-Pacific, Europe and North America with different backgrounds including basic scientists and clinical practitioners